Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions
- PMID: 38438600
- PMCID: PMC10912755
- DOI: 10.1038/s41598-024-56061-x
Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions
Abstract
This study investigates the risk of chronic kidney disease (CKD) across four metabolic phenotypes: Metabolically Healthy-No Obesity (MH-NO), Metabolically Unhealthy-No obesity (MU-NO), Metabolically Healthy-Obesity (MH-O), and Metabolically Unhealthy-Obesity (MU-O). Data from the Tehran Lipid and Glucose Study, collected from 1999 to 2020, were used to categorize participants based on a BMI ≥ 30 kg/m2 and metabolic health status, defined by the presence of three or four of the following components: high blood pressure, elevated triglycerides, low high-density lipoprotein, and high fasting blood sugar. CKD, characterized by a glomerular filtration rate < 60 ml/min/1.72 m2. The hazard ratio (HR) of CKD risk was evaluated using Cox proportional hazard models. The study included 8731 participants, with an average age of 39.93 years, and identified 734 incidents of CKD. After adjusting for covariates, the MU-O group demonstrated the highest risk of CKD progression (HR 1.42-1.87), followed by the MU-NO group (HR 1.33-1.67), and the MH-O group (HR 1.18-1.54). Persistent MU-NO and MU-O posed the highest CKD risk compared to transitional states, highlighting the significance of exposure during early adulthood. These findings emphasize the independent contributions of excess weight and metabolic health, along with its components, to CKD risk. Therefore, preventive strategies should prioritize interventions during early-adulthood.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10912755/bin/41598_2024_56061_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10912755/bin/41598_2024_56061_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10912755/bin/41598_2024_56061_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10912755/bin/41598_2024_56061_Fig4_HTML.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10912755/bin/41598_2024_56061_Fig5_HTML.gif)
Similar articles
-
Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis.Obes Rev. 2024 Feb;25(2):e13656. doi: 10.1111/obr.13656. Epub 2023 Oct 30. Obes Rev. 2024. PMID: 37904643 Review.
-
Metabolically unhealthy phenotype in normal weight population and risk of mortality and major adverse cardiac events: A meta-analysis of 41 prospective cohort studies.Diabetes Metab Syndr. 2022 Oct;16(10):102635. doi: 10.1016/j.dsx.2022.102635. Epub 2022 Sep 29. Diabetes Metab Syndr. 2022. PMID: 36240685 Review.
-
Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):2017-2026. doi: 10.1016/j.numecd.2020.06.025. Epub 2020 Jul 1. Nutr Metab Cardiovasc Dis. 2020. PMID: 32826134
-
Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgaa033. doi: 10.1210/clinem/dgaa033. J Clin Endocrinol Metab. 2020. PMID: 31967306
-
Metabolically healthy obesity and risk of incident CKD.Clin J Am Soc Nephrol. 2015 Apr 7;10(4):578-83. doi: 10.2215/CJN.08980914. Epub 2015 Jan 29. Clin J Am Soc Nephrol. 2015. PMID: 25635035 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials